Leadership1 publisher3 min readPublished
Clinicians answer the AI cure-for-cancer claim with more than 100 brain tumour types
A Melbourne oncologist told the Guardian she doubts a cure for all cancer inside 10 years, and the clinicians who said so expect the real gains in diagnostics, pathology and treatment selection. Those are steps a budget can be written against.
The Board Room · Leadership desk

What happened
- The Guardian reports AI chief executives promising a cure for cancer in five to 10 years or within our lifetimes, in the same public conversation that has AI causing human extinction before 2030.
- Ajit Goenka of the Mayo Clinic named the steps AI can improve: identifying risk, detecting disease, characterising tumours, selecting treatments and monitoring.
- AI is already in clinical use in some places, reading lung imagery for early signs of malignancy and helping to remove brain tumours.
Compiled by The Board RoomSomething wrong?How this is made
Why it matters
- constraint Money aimed at curing cancer has no single object to buy. It has to be split by tumour type and by pathway step before anyone can attach a milestone to it.
- decision A planner is choosing between two forecasts with different audit horizons: diagnostics and pathology gains report numbers inside a budget cycle, and the cure does not.
- contradiction The same executive claims run in both directions, a cure by the mid-2030s and extinction before 2030, which lowers what either figure is worth as a planning input.
The promise has a definition problem before it has a scheduling problem. Cancer is a catch-all term for the uncontrollable growth of abnormal cells, usually named for the part of the body where it is found, and the diseases under that label differ in the cells they affect and in the genetic changes behind them [5]. Felix Sahm, a neuropathologist at University Hospital Heidelberg, told the Guardian that "there are more than 100 types of tumours in the brain, much more than in any other single organ" [7]. Sahm also said there are "so many unresolved questions in brain tumour research and brain tumour care" [8]. The Guardian's own verdict is that a single cure is "not only unlikely but nigh on impossible" [6].
Look at one cancer. Pancreatic cancer is the 12th most common cancer worldwide and the sixth most common cause of cancer death [10]. It ranks six places higher for deaths than for frequency [13]. The World Health Organization calls it "one of the cancer types with the least favourable prognosis" [11]. The gains of the past century arrived one modality at a time: chemotherapy and radiation made some solid tumours curable, and monoclonal antibodies allowed more direct targeting of abnormal cells [16].
The clinicians describe work at named points in a pathway. "AI can improve several parts of that process by helping us identify risk, detect disease, characterise tumours, select treatments and monitor," said Ajit Goenka, a radiologist and nuclear medicine specialist at the Mayo Clinic in Minnesota [9]. Loi and the other experts the Guardian interviewed expect efficiencies in treatment, diagnostics and pathology services, and more personalised and more equitable care [4]. Some of this is already clinical, including models reading lung imagery for early signs of malignancy and systems assisting the removal of brain tumours [12].
Pitched to funders, the claim is one sentence: AI cures cancer in five to 10 years, so the health line gets funded as a moonshot [1]. The pitch drops the unit of work, and it sits alongside claims that AI is responsible for human extinction before 2030 [2]. The Guardian reports those proclamations and does not say which executives made them [15]. A forecast that names no tumour type, no endpoint and no trial cannot be checked against anything in a planning cycle.
"Until AI can actually think and do experiments itself at scale, I'm not sure that we're going to find a cure for all cancer or medical illness in the next 10 years," said Sherene Loi, a medical oncologist at the Peter MacCallum Cancer Centre in Melbourne [3]. She set a condition, and she also said "Human disease is very complex" [14]. For a budget written this quarter, the fundable item is a detection or pathology step that reports a number inside the cycle; the cure claim will not resolve before several more planning rounds have closed.
What to watch
- Whether any executive attaches a named tumour type, an endpoint and a trial to the five-to-ten-year claim.
- Published accuracy or turnaround figures from the lung imaging and pathology uses already running in clinics.
- Whether the more equitable care the clinicians expect shows up as access data and not only model performance.